Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Background and aims The main causes of death in patients with severe Coronavirus
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …
Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: an …
X Xu, W Jiang, L Chen, Z Xu, Q Zhang… - Clinical and …, 2021 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) was identified in December 2019 and has …
syndrome coronavirus 2 (SARS‐CoV‐2) was identified in December 2019 and has …
Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products
M Mebarki, C Abadie, J Larghero, A Cras - Stem Cell Research & Therapy, 2021 - Springer
Umbilical cord-derived mesenchymal stem/stromal cells (UC-MSCs) emerge as a
perspective for therapeutic use in immune and inflammatory diseases. Indeed …
perspective for therapeutic use in immune and inflammatory diseases. Indeed …
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
Z Li, S Niu, B Guo, T Gao, L Wang, Y Wang… - Cell …, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 …
caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 …
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
S Juul, EE Nielsen, J Feinberg, F Siddiqui… - PLoS …, 2020 - journals.plos.org
Background Coronavirus disease 2019 (COVID-19) is a rapidly spreading disease that has
caused extensive burden to individuals, families, countries, and the world. Effective …
caused extensive burden to individuals, families, countries, and the world. Effective …
Mesenchymal stem cell therapy for severe COVID-19
L Shi, L Wang, R Xu, C Zhang, Y Xie, K Liu… - Signal transduction and …, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health …
syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health …
Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises
L Rezakhani, AF Kelishadrokhi… - Chemistry and physics …, 2021 - Elsevier
There are no commercially available effective antiviral medications or vaccines to deal with
novel coronavirus disease (COVID-19). Hence there is a substantial unmet medical need for …
novel coronavirus disease (COVID-19). Hence there is a substantial unmet medical need for …
[HTML][HTML] Mesenchymal stem cell treatment for COVID-19
R Xu, Z Feng, FS Wang - EBioMedicine, 2022 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a
global pandemic since late 2019 that resulted in more than 360 million population infection …
global pandemic since late 2019 that resulted in more than 360 million population infection …
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
CLK Rebelatto, AC Senegaglia, CL Franck… - Stem cell research & …, 2022 - Springer
Background COVID-19 is a multisystem disease that presents acute and persistent
symptoms, the postacute sequelae (PASC). Long-term symptoms may be due to …
symptoms, the postacute sequelae (PASC). Long-term symptoms may be due to …
Cell-based therapy for severe COVID-19 patients: clinical trials and cost-utility
A Golchin - Stem cell reviews and reports, 2021 - Springer
The race among countries and companies to develop efficacious vaccines and therapeutics
for the COVID-19 is ongoing fast, with many trials underway. Among this, cell-based therapy …
for the COVID-19 is ongoing fast, with many trials underway. Among this, cell-based therapy …